Introduction ulphonamides constitute a class of organosulphur compounds and are extensively used as anticancer 1 , antitumour 2 , antiviral 3 , antimalarial 4 , antidiabetic 5 , antihypertensive 6 , antituberculosis 7 , antiosteoarthiritis 8 , anticataract 9 , antidiuretics 10 , antimigraine 11 , antiretroviral 12 , and inhibitors of carbonic anhydrase, among others. Some of these sulpha drugs that have performed ''healing magic'' in the world of therapy include Sulphonilamide 1, Sulphadozin 2, Sulphadiazine 3, Sulphanilamide 4, Sulphamonomethoxine 5 and Sulphamethiazole 6. The target of sulphonamide drugs and the basis of their selectivity is the enzyme dihydropteroate synthase (DHPS) in the folic acid pathway. 13 Nowadays, sulphonamides drugs are occasionally used due to horizontal spread of resistance genes, expressing drug-insensitive variants of target enzymes dihydropteroate synthase. 14 The challenge of the emergence S of multidrug resistance micro-organism to clinically used sulphonamide drugs has revived a dedicated search for new antimicrobial drugs to combat rapid spread of harmful microorganisms. [15] [16] [17] [18] [19] [20] Sondhi et al synthesized some methanesulphonamides by condensation of 3, 4-diaryl-2-imino-4-thiazolines with methanesulphonyl chloride and found out that they possess anti-inflammatory and anticancer activities. 21 Nassir and his group synthesized N-4-methylbenzenesulphonyl N-(4-methylbenzenesulphonyl)-benzimidazol-2-ylmethylthio)benzimidazole in good yields from 2-(benzimidazole-2-yl) methylthio)-benzimidazole. 22 A series of quinazolonyl derivatives of 4-oxothiazolidinyl sulphonamides were synthesized and were found to have remarkable antibacterial activity against Bacillus subtilis, Bacillus cereus, Candida albican. 23 In a six-step synthesis, Chen and co-workers synthesized N, N-disubstututed 1, 3, 4-thiadiazole-2-sulphonamide derivatives that exhibited certain anti tobacco mosaic virus activity. 24 Also, antimalarial properties of new carboxamides bearing sulphonamide were recently reported. 25 In this article, we described the synthesis of phenylsulphonylaminoalkanamides and N -aryl ptoluenesulphonamides as medicinally relevant new sulphonamides.
Results And Discussion

Synthesis
The reaction of benzenesulphonyl chloride 7 with valine 8 under basic condition at room temperature afforded 3-methyl-2-[(phenylsulphonyl)amino]butanoic acid 9 in 75% yields. Compound 9 which is a white crystalline compound, melting at 133-134 o C, was prepared as described. 26 Heating of a mixture of compound 9 in acetic anhydride and glacial acetic acid under refluxing condition provided 2-[acetyl (phenylsulphonyl)]-3-methylbutanoic acid 10 as a white crystalline solid compound at 85% yield, melting at 102 -103 o C. The spectral and analytical data supported the assigned molecular structure of compound 10. absorption bands for -NH 2 , C=O for amide and S=O appeared at 3262 cm -1 , 1708 cm -1 and 1382 cm -1 , respectively. The proton nuclear magnetic resonance absorption at δ 7.87 -7.56 (multiplet, 5H) was assigned to aromatic protons, δ 3.60 (singlet, 2H) is due to NH 2 protons, δ 3.08 (singlet, 3H) is due to -CH 3 protons, δ 1.87 -1.35 (doublet, 1H) is due to C-H protons and δ 0.97 -0.87 (doublet, 6H) is due to 2CH 3 protons. Other spectral data are in agreement with the molecular structure of compound 11.
The -NH 2 moiety of the amide group was taken advantage in further conversion of the compound 11 via palladium acetate and triphenylphosphine catalytic cross-coupling afforded mutifuntionalised phenylsulphonylaminobutanamide 13a-13c in good yields. Furthermore, the reaction of compound 11 with 2-chloro-5-nitropyridine and 6-chloro-2, 4-diaminopyrimidine heterocycles provided compounds 13e and 13f respectively after recrystallisation from mixture tertiary butanol and methanol in ratio (1:3). 
Assessment of oral bioavailability property
The physicochemical properties generated by in-silico study which were used to assess the possibilities of the synthesized compounds to be bioavailable in the systemic circulation should be formulated and administered orally as a drug. Lipinski "rule of five" (ro5) and total polar surface area (TPSA) were employed to assess the bioavailability of these compounds. Lipinski's ro5 proposed that for a molecule to be drug-like, the molecule should have lipophilicity (log P) ≤ 5, molecular weight (MW) ≤ 500, number of hydrogen bond acceptor (HBA) ≤ 10, and number of hydrogen bond donor (HBD) ≤ 5. The ro5 stipulates that a drug candidate which violates more than one property will have bioavailability problem. According to Table 1 , all the synthesized compounds obeyed Lipinski ro5. This, therefore, implies that the compounds have drug-likeness and will be bioavailable should they be formulated as drugs and orally administered. In the same . 
Docking studies
Mutant Human Androgen Receptor (1GS4) derived from an Androgen-Independent Prostate Cancer and Human Mitogenactivated protein kinase 1 (3PP1) are important drug targets for the development of new therapeutic treatments for androgen-independent prostate cancer. 29 These two cancer targets were used in the study to evaluate the binding affinity and chemical interactions of the synthesized compounds with the targets. The result in table 3 reveals that all the synthesized compounds have certain degree of affinity with the targets. There was no significant difference 2019, 2(4), 151-161 http://jmchemsci.com 11.86 kcal/mol) ( Table 3) . From the foregoing, it can easily be noted that compounds 13c, 13f and 10 show comparable binding affinity with methothrexate. Therefore, the binding pose of the these compounds and methothrexate in the catalytic sites of the cancer receptors were further studied and the result shown in figures 1-4. were the common amino acids involved in the interaction with methothrexate and compound 10. The details of the amino acid residues interacting with the compounds, their distance of interactions and the type of interactions have been outlined in tables 4a and bb. A study disclosed that MET 143, in addition to other amino acid residues, were responsible for the inhibitory activity of 2-fluoro-4-iodoaniline which was found to bind in the lipophilic pockets of 3PP1.
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Conclusion
The synthesis of 2-[acetyl(phenylsulphonyl)amino-3-methylbutanamine 11 and its transformation to various derivatives via Buchwald-Hartwig tandem amidation was
Experimental
General
All the starting materials and reagents were of technical grade obtained from Sigma-Aldrich and were used without further purification. The melting points were determined with a Fischer John's melting point apparatus and were uncorrected. IR spectra were recorded on a 8400s Fourier Transform Infrared (FTIR) spectrophotometer and were reported in wave number. IR analysis was done at Department of Chemistry, University of Lagos. Nuclear Magnetic Resonance ( 1 H-NMR and 13 C-NMR) specrtra were determined using a Jeol 700MH spectrometer at University of Newcastle, United Kingdom. Chemical shifts are reported in (δ) scale. Elemental analysis was carried out with ThermoQuest FLASH series (CHNS) elemental analyzer .
In-silico physicochemical evaluation
The molecular weight (MW), number of rotatable bonds (NoRB), partition coefficient (log P), hydrogen bond acceptor (HBA), hydrogen bond donor (HBD) and TPSA were calculated using Molinspiration Chemoinformatics software 2016.
Molecular docking studies
Preparation of ligands
ACD/ChemSketch 2015 was used to draw the structures of compounds. 31 
Preparation of protein targets
The 3D crystal structures of two cancer receptor cells namely: Mutant Human Androgen Receptor (pdb code: 1 GS4) and human mutogen-activated kinase 1 (pdb code: 3 PP1) were retrieved from the RCSB Protein Data Bank (PDB) (www.rcsb.org/pdb/home/home.do). All bound ligands, cofactors, and water molecules were removed from the proteins using Discovery Studio Visualizer v16. 1.0. 15350. All file conversions required for the docking study were performed using the open source chemical toolbox Open Babel version 2.3.2 (www.openbabel.org).
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Molecular docking experiments
In an effort to identify potential anti-cancer lead (s) among the synthesized compounds, docking calculations using Autodock v4.0.1 into the 3D structure of the catalytic sites of 1gs4 and 3pp1 were carried out. 33 The Gasteiger charge calculation method was used and partial charges were added to the ligand atoms prior to docking. 34 The Lamarckian genetic algorithm (LGA), which is available in Auto Dock was employed. 35 Finally, Auto Dock was used to calculate the binding free energy of a given inhibitor conformation in the macromolecular structure.
Synthesis 2-[Acetyl (phenylsulphonyl) ]-3-methylbutanoic acid (10)
To a mixture of acetic anhydride (10 mL) and glacial acetic acid (10 mL) was carefully added to 3-methyl [(phenylsulphonyl) amino] butanoic acid (6 g ) and the reaction reflixed at 90 o C for 45 min. At the end of the reaction, the reaction mixture was cooled to room temperature before being poured directly into 100 mL of cold water and stirred vigorously to obtained shining crystals of the product after filtration. % Yield = 2.52 g (71%) 
Synthesis 2-[Acetyl (phenylsulphonyl) amino3methylbutanamide (11)
A solution of 2-[acetyl (phenylsulphonyl) amino]-3-methybutanoic acid (10 mmol) and t-butanol (10 mL) was cooled to 0 o C. Thionyl chloride (1.10 mL, 1mmol) was added and the entire mixture refluxed for 3 h. The excess thionyl chloride which was evaporated off to obtain a crude acid chloride was dissolved in t-butanol (10 mL) and this solution was cooled to 0 o C. In a separate reaction, t-butanol (10 mL) was added to ammonia (0.17 g, 10 mmol) and the mixture was cooled to 0 o C. The crude acid chloride was then added dropwise to the ammonia solution at such a rate that the temperature was maintained below 5 o C. Upon completion of the addition of the acid chloride solution, the mixture was shaken intermitently at 0 o C for 3 h. The reaction mixture was filtered, washed with t-butanol and dried to afford the tilled product.Yield 
General procedure for the synthesis of the derivatives 13a-f
A mixture of palladium acetate (89 mg, 0.045 mmol), water (5 mmol) and triphenylphosphine (89 mg, 0.045 mmol) was heated for 2 min at 110 o C in t-butanol. Thereafter, potassium phosphate (180 mg, 1 mol), amide (41 mg, 1mol) and aryl halide (250 mg, 1 mol) were added and heating continued under refluxed for 3 h to give the derivatives. These solutions were filtered, the filtrate allowed to evaporate to dryness and 
Synthesis of 2-[Acetyl (phenylsulphonyl) amino]-N-(2,6-diaminopyrimidin-4-yl)-3-methyl butanamide (13f).
A 2-[acetyl (phenylsulphonyl) amino-3-methylbutanamide (2) reacted with 6-chloropyrimidine-2,4-diamine to provide the titled compound (4) 
Synthesis of 4-methylbenzenesulphonamide (15)
A mixture of ammonium hydroxide (1.4 g, 40 mmol) and ptoluenesulphonyl chloride (3.81 g , 20 mmol) was stirred for 5min at room temperature and as the mixture warmed up slightly and thickened to a paste, 20ml of distilled water was added and stirring continued for 3 min. The mixture was further heated on a water bath at temperature of 60 -70 o C for 2 min and chilled in ice-water. The precipitates formed was collected by filtration, air-dried and recrystalised from aqueous ethanol to give low melting crystalline solid as product, yield = 3.27g (96%), mp 58 
General Procedure for Synthesis of para-aryl derivatives of 4-methyl benzene sulphonamide (17a-e).
A mixture of bis (triphenylphosphine) nickel (II) chloride (0.3 g, ), triphenylphosphine (0.9 g, 3 mmol, t-butanol (4 mL) and water (2 mL) was refluxed under nitrogen atmosphere with stirring for 1h at a temperature of 110 o C until the reaction was completed. The entire mixture was then cooled at room temperature, diluted with ethyl acetate, washed with water to afford aryl substituted p-toluenesulphonamide in good yields. These products were purified by recrystallisation from aqueous methanol. The general procedure was applied to prepare compounds 17a-17d. 
Synthesis
